CV Sciences (CVSI) Cash & Equivalents (2010 - 2026)

CV Sciences has disclosed Cash & Equivalents across 17 years of filings, most recently posting $309000.0 for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $309000.0, down 61.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $309000.0 (down 61.95% YoY), and the FY2025 annual result was $278000.0, down 38.77% from the prior year.
• Cash & Equivalents came in at $309000.0 for Q1 2026 at CV Sciences, up from $278000.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.4 million in Q1 2022 to a low of $278000.0 in Q4 2025.
• The 5-year median for Cash & Equivalents is $812000.0 (2025), against an average of $935588.2.
• Across the five-year window, Cash & Equivalents soared 115.55% in 2023 and sank 71.78% in 2024, its largest moves.
• CV Sciences' Cash & Equivalents stood at $611000.0 in 2022, then jumped by 115.55% to $1.3 million in 2023, then plunged by 65.53% to $454000.0 in 2024, then sank by 38.77% to $278000.0 in 2025, then increased by 11.15% to $309000.0 in 2026.
• The last three Cash & Equivalents figures came in at $309000.0 (Q1 2026), $278000.0 (Q4 2025), and $381000.0 (Q3 2025), per Business Quant data.